Table 2 Cox hazard ratios (HRs) for recurrence in FinXX samples

From: Distinct spatial immune microlandscapes are independently associated with outcomes in triple-negative breast cancer

Protein

Intraepithelial univariable HR (95% CI)

p-value

Stroma univariable HR (95% CI)

p-value

Intraepithelial multivariable HR (95% CI)

p-value

Stroma multivariable HR (95% CI)

p-value

B2M

0.458 (0.169, 1.244)

0.116

0.338 (0.114, 1.000)

0.040

0.532 (0.194, 1.456)

0.219

0.415 (0.138, 1.247)

0.117

CD11c

0.321 (0.109, 0.951)

0.031

0.787 (0.321, 1.932)

0.601

0.402 (0.133, 1.212)

0.106

1.395 (0.544, 3.578)

0.488

CD20

0.318 (0.108, 0.942)

0.029

0.817 (0.333, 2.005)

0.658

0.283 (0.095, 0.839)

0.023

0.718 (0.292, 1.768)

0.471

CD40

0.210 (0.062, 0.713)

0.006

0.321 (0.109, 0.951)

0.031

0.278 (0.081, 0.953)

0.042

0.570 (0.179, 1.817)

0.342

CD56

0.209 (0.062, 0.710)

0.006

0.452 (0.166, 1.226)

0.109

0.206 (0.061, 0.701)

0.011

0.473 (0.174, 1.285)

0.142

GZMB

0.430 (0.158, 1.167)

0.088

0.465 (0.171, 1.261)

0.123

0.179 (0.062, 0.517)

0.001

0.168 (0.058, 0.490)

0.001

HLA-DR

0.204 (0.060, 0.695)

0.005

1.488 (0.634, 3.490)

0.358

0.263 (0.077, 0.905)

0.034

1.628 (0.692, 3.829)

0.264

ICOS

0.208 (0.061, 0.704)

0.005

0.644 (0.252, 1.646)

0.354

0.229 (0.067, 0.779)

0.018

0.836 (0.321, 2.176)

0.713

IDO1

0.224 (0.066, 0.759)

0.009

0.224 (0.066, 0.759)

0.009

0.358 (0.099, 1.292)

0.117

0.439 (0.092, 2.093)

0.302

PD-L1

0.610 (0.239, 1.560)

0.297

0.821 (0.334, 2.014)

0.666

0.530 (0.206, 1.359)

0.186

0.936 (0.379, 2.314)

0.886

PD-L2

0.914 (0.373, 2.243)

0.845

0.691 (0.270, 1.766)

0.437

0.660 (0.266, 1.637)

0.370

0.561 (0.218, 1.442)

0.230

  1. HRs were calculated using protein abundance (All Intraepithelial or All Stroma, as defined in the legend in Table 1) and time to event as continuous variables. Univariable and multivariable (adjusted for sTILs) HRs and p-values for 11 proteins (10 differentially expressed at BYadj p < 0.05 plus PD-L1). Bold font indicates two-sided p < 0.05. p-values were adjusted for stromal tumor-infiltrating lymphocytes (sTILs). Source data are given in Supplementary Table 2.